Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITAN trial of lefitolimod and broadly neutralizing antibodies during analytical treatment interruption in HIV
2018-001165-16Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2018
- Modality
- Vaccines & Immunotherapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of lefitolimod, Teropavimab and zinlirvimab in human immunodeficiency virus infection (HIV) (4 arms), sponsored by Aarhus University Hospital. Started Sep 2018; status: completed.
02
Drugs
lefitolimodTeropavimabzinlirvimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2018-001165-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001165-16.